Literature DB >> 8329802

Magnesium and diabetes: a review.

J R White1, R K Campbell.   

Abstract

OBJECTIVE: To discuss the potential link between diabetes mellitus (DM) and hypomagnesemia, the methods used to assess magnesium status, and the potential benefits of magnesium repletion in hypomagnesemic patients with DM. DATA SOURCES: A MEDLINE search (key terms: magnesium and diabetes) was conducted to identify pertinent literature. STUDY SELECTION: All major clinical trials and most published case reports were reviewed. SYNTHESIS: Several studies have demonstrated a higher than expected frequency of magnesium deficiency in patients with DM. Hypomagnesemia may play a role in the development of retinopathy, altered glucose disposition, hypertension, abnormal platelet function, and other problems frequently observed in patients with DM. The lack of a widely available, accurate screening methodology is one of the main problems in assessing total body magnesium status. One study has suggested that hypomagnesemia in patients with DM may be related to enhanced urinary loss of magnesium. Several studies evaluating hypomagnesemia and glucose disposal have suggested a direct correlation between magnesium concentration and glucose disposal, with an improvement in glucose disposal with magnesium supplementation. It has been suggested that there is a relationship between hypomagnesemia and diabetic retinopathy; however, the effect of magnesium supplementation on the development of diabetic retinopathy has not been evaluated. Researchers evaluating the effect of magnesium on platelet aggregation have suggested that magnesium supplementation may reduce the incidence of vascular disease in hypomagnesemic patients with DM. Several studies have demonstrated a correlation between hypomagnesemia and hypertension.
CONCLUSIONS: Studies have suggested a link between hypomagnesemia and hyperglycemia, as well as an association between hypomagnesemia and the complications of DM. The American Diabetes Association has published a consensus statement suggesting that patients who have documented hypomagnesemia and DM receive magnesium supplementation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8329802     DOI: 10.1177/106002809302700619

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  10 in total

1.  Isolation and characterization of magbane, a magnesium-lethal mutant of paramecium.

Authors:  J A Hammond; R R Preston
Journal:  Genetics       Date:  2001-07       Impact factor: 4.562

2.  Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.

Authors:  Rebecca B Costello; Ronald J Elin; Andrea Rosanoff; Taylor C Wallace; Fernando Guerrero-Romero; Adela Hruby; Pamela L Lutsey; Forrest H Nielsen; Martha Rodriguez-Moran; Yiqing Song; Linda V Van Horn
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

3.  Muscle cramps and magnesium deficiency: case reports.

Authors:  D L Bilbey; V M Prabhakaran
Journal:  Can Fam Physician       Date:  1996-07       Impact factor: 3.275

4.  Insulin modulation of intracellular free magnesium in heart: involvement of protein kinase C.

Authors:  T Amano; T Matsubara; J Watanabe; S Nakayama; N Hotta
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 5.  Management of glycemia in diabetic patients with stage IV and V chronic kidney disease.

Authors:  Andrea Roche-Recinos; Esti Charlap; Mariana Markell
Journal:  Curr Diab Rep       Date:  2015-05       Impact factor: 4.810

6.  The incidence of hypomagnesaemia following abdominal aortic aneurysm surgery.

Authors:  K Jolly; R Faulconer; R McEwan; H Becker; A Garnham
Journal:  Ann R Coll Surg Engl       Date:  2015-07       Impact factor: 1.891

7.  Hypomagnesemia and the Risk of New-Onset Diabetes Mellitus after Kidney Transplantation.

Authors:  Johnny W Huang; Olusegun Famure; Yanhong Li; S Joseph Kim
Journal:  J Am Soc Nephrol       Date:  2015-10-08       Impact factor: 10.121

Review 8.  Ion channels and transporters in diabetic kidney disease.

Authors:  Denisha Spires; Anna D Manis; Alexander Staruschenko
Journal:  Curr Top Membr       Date:  2019-02-18       Impact factor: 3.049

9.  Quadriparesis in diabetes due to dyselectrolytemia.

Authors:  Arundhati Dasgupta; Uma K Saikia; Dipti Sharma; Mihir Saikia; S Dutta Choudhury
Journal:  Indian J Endocrinol Metab       Date:  2010-01

10.  Famotidine induced hypomagnesemia leading to hypocalcemia.

Authors:  Rajesh Essrani; Shehriyar Mehershahi; Shri Jai Kirshan Ravi; Rajesh Kumar Essrani; Anuraj Sudhakaran; Muhammad Hossain; Tsu Jung Yang; Asif Mehmood
Journal:  Oxf Med Case Reports       Date:  2020-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.